Nephrological Center, Medical Policlinic, University of Munich, Munich, Germany.
PLoS One. 2011;6(10):e26778. doi: 10.1371/journal.pone.0026778. Epub 2011 Oct 27.
IL-1β and IL-18 are proinflammatory cytokines that contribute to renal immune complex disease, but whether IL-1β and IL-18 are mediators of intrinsic glomerular inflammation is unknown. In contrast to other cytokines the secretion of IL-1β and IL-18 requires a second stimulus that activates the inflammasome-ASC-caspase-1 pathway to cleave pro-IL-1β and -IL-18 into their mature and secretable forms. As the NLRP3 inflammasome and caspase-1 were shown to contribute to postischemic and postobstructive tubulointerstitial inflammation, we hypothesized a similar role for NLRP3, ASC, and caspase-1 in glomerular immunopathology. This concept was supported by the finding that lack of IL-1R1 reduced antiserum-induced focal segmental necrosis, crescent formation, and tubular atrophy when compared to wildtype mice. Lack of IL-18 reduced tubular atrophy only. However, NLRP3-, ASC- or caspase-1-deficiency had no significant effect on renal histopathology or proteinuria of serum nephritis. In vitro studies with mouse glomeruli or mesangial cells, glomerular endothelial cells, and podocytes did not reveal any pro-IL-1β induction upon LPS stimulation and no caspase-1 activation after an additional exposure to the NLRP3 agonist ATP. Only renal dendritic cells, which reside mainly in the tubulointerstitium, expressed pro-IL-1β and were able to activate the NLRP3-caspase-1 axis and secrete mature IL-1β. Together, the NLRP3-ASC-caspase-1 axis does not contribute to intrinsic glomerular inflammation via glomerular parenchymal cells as these cannot produce IL-1β during sterile inflammation.
IL-1β 和 IL-18 是促炎细胞因子,有助于肾脏免疫复合物疾病,但 IL-1β 和 IL-18 是否是固有肾小球炎症的介质尚不清楚。与其他细胞因子不同,IL-1β 和 IL-18 的分泌需要第二个刺激物激活炎症小体-ASC-半胱天冬酶-1 途径,将前体 IL-1β 和 -IL-18 切割成成熟和可分泌的形式。由于 NLRP3 炎症小体和半胱天冬酶-1 被证明有助于缺血后和梗阻后肾小管间质炎症,我们假设 NLRP3、ASC 和半胱天冬酶-1 在肾小球免疫病理学中也具有类似的作用。这一概念得到了以下发现的支持:与野生型小鼠相比,缺乏 IL-1R1 可减少抗血清诱导的局灶性节段性坏死、新月体形成和肾小管萎缩。缺乏 IL-18 仅减少肾小管萎缩。然而,NLRP3、ASC 或半胱天冬酶-1 缺陷对肾脏组织病理学或血清肾炎蛋白尿没有显著影响。用小鼠肾小球或系膜细胞、肾小球内皮细胞和足细胞进行的体外研究表明,LPS 刺激不会诱导前体 IL-1β,并且在额外暴露于 NLRP3 激动剂 ATP 后不会激活半胱天冬酶-1。只有主要位于肾小管间质的肾脏树突状细胞表达前体 IL-1β,并且能够激活 NLRP3-半胱天冬酶-1 轴并分泌成熟的 IL-1β。总之,NLRP3-ASC-半胱天冬酶-1 轴不会通过肾小球实质细胞导致固有肾小球炎症,因为这些细胞在无菌性炎症期间不能产生 IL-1β。